Executive Summary
A global MedTech leader was driving an advanced robotic-assisted surgical system toward commercialization and needed roughly 30% cost out of its three most expensive subsystems, without touching fit, form, function or reliability. LTTS ran Value Analysis and Value Engineering concurrently with live verification and validation, delivering approximately 32% savings and around USD 15 million in unlocked product value with no impact to the launch timeline.
Read the Full Case Study. Anytime, Anywhere
Download Case StudyClient Challenge
Cost reduction on a robotic surgery platform is never only a design problem. Every decision reaches into manufacturing, suppliers, assembly, validation and serviceability, and on a Class-grade platform each carries a regulatory shadow. The obvious route, pausing to value engineer, would have cost the launch window. Altering anything a regulator or a surgeon would notice would have reopened V&V already in flight. So the brief was uncomfortable by design: find real money inside a system that was not allowed to visibly change, and leave the platform cheaper to build for every variant that follows.
Engineering Complexity - Why It Was Hard
The difficulty was sequencing, not ideation.
Concurrency was the constraint
Every accepted idea had to be tested against whether it invalidated a protocol already executed. A saving that reopens validation is a net loss, and that call had to be made hundreds of times.
The system is coupled
A part change in the Robotic Arm shifts mass distribution, which touches motion control, which touches validation. No lever moves independently
Ideas are cheap, feasibility is not
Proving which changes hold function is where most VAVE programs quietly fail.
Serviceability is a hidden cost floor
Fewer parts can mean longer field service, reversing the saving across the product life.
Business Outcomes
32%
Savings
Beating target and spread across Patient Cart, Surgeon Console and Robotic Arm rather than concentrated in one subsystem.
15 mn USD
Unlocked
The aggregate of 145 individually engineered changes, not a modeled projection.
50%
Fewer machining operations
The largest manufacturing lever and the one that compounds with volume.
27%
Fewer custom parts
Cutting unit cost, supply risk and qualification time for future variants.
Success Stories